U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07501611) titled 'Acute Cardiovascular Effects of Transcutaneous Auricular Vagus Nerve Stimulation' on March 17.
Brief Summary: Introduction
Cardiovascular disease (CVD) remains the leading cause of mortality worldwide, with arterial hypertension representing the most significant modifiable risk factor (Lim et al., 2012; Mills et al., 2020). While clinical manifestations of arterial hypertension typically emerge in later life, the underlying pathophysiological mechanisms, particularly autonomic dysfunction, begin decades earlier.
Autonomic imbalance, characterised by sympathetic overactivity and diminished parasympathetic tone, not only precedes s...